Package 61919-213-30

{"route": ["ORAL"], "spl_id": "4c490e55-407d-a23d-e063-6394a90ac099", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["199889"], "spl_set_id": ["164cb1f7-1a41-675f-e063-6294a90ae0dd"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["C"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (61919-213-30)", "package_ndc": "61919-213-30", "marketing_start_date": "20240417"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (61919-213-60)", "package_ndc": "61919-213-60", "marketing_start_date": "20240417"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (61919-213-72)", "package_ndc": "61919-213-72", "marketing_start_date": "20240417"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (61919-213-90)", "package_ndc": "61919-213-90", "marketing_start_date": "20240417"}], "brand_name": "Topiramate", "product_id": "61919-213_4c490e55-407d-a23d-e063-6394a90ac099", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "61919-213", "generic_name": "Topiramate", "labeler_name": "C", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "100 mg/1"}], "application_number": "ANDA076343", "marketing_category": "ANDA", "marketing_start_date": "20240417", "listing_expiration_date": "20271231"}